Cong M, Perry S J, Lin F T, Fraser I D, Hu L A, Chen W, Pitcher J A, Scott J D, Lefkowitz R J
Howard Hughes Medical Institute, Departments of Medicine and Biochemistry, Duke University Medical Center, Durham, North Carolina 27710, USA.
J Biol Chem. 2001 May 4;276(18):15192-9. doi: 10.1074/jbc.M009130200. Epub 2001 Jan 22.
The beta2 adrenergic receptor (beta2AR) undergoes desensitization by a process involving its phosphorylation by both protein kinase A (PKA) and G protein-coupled receptor kinases (GRKs). The protein kinase A-anchoring protein AKAP79 influences beta2AR phosphorylation by complexing PKA with the receptor at the membrane. Here we show that AKAP79 also regulates the ability of GRK2 to phosphorylate agonist-occupied receptors. In human embryonic kidney 293 cells, overexpression of AKAP79 enhances agonist-induced phosphorylation of both the beta2AR and a mutant of the receptor that cannot be phosphorylated by PKA (beta2AR/PKA-). Mutants of AKAP79 that do not bind PKA or target to the beta2AR markedly inhibit phosphorylation of beta2AR/PKA-. We show that PKA directly phosphorylates GRK2 on serine 685. This modification increases Gbetagamma subunit binding to GRK2 and thus enhances the ability of the kinase to translocate to the membrane and phosphorylate the receptor. Abrogation of the phosphorylation of serine 685 on GRK2 by mutagenesis (S685A) or by expression of a dominant negative AKAP79 mutant reduces GRK2-mediated translocation to beta2AR and phosphorylation of agonist-occupied beta2AR, thus reducing subsequent receptor internalization. Agonist-stimulated PKA-mediated phosphorylation of GRK2 may represent a mechanism for enhancing receptor phosphorylation and desensitization.
β2肾上腺素能受体(β2AR)通过蛋白激酶A(PKA)和G蛋白偶联受体激酶(GRK)使其磷酸化的过程发生脱敏。蛋白激酶A锚定蛋白AKAP79通过在膜上使PKA与受体形成复合物来影响β2AR的磷酸化。我们在此表明,AKAP79还调节GRK2使激动剂占据的受体磷酸化的能力。在人胚肾293细胞中,AKAP79的过表达增强了激动剂诱导的β2AR和不能被PKA磷酸化的受体突变体(β2AR/PKA-)的磷酸化。不结合PKA或不靶向β2AR的AKAP79突变体显著抑制β2AR/PKA-的磷酸化。我们表明,PKA直接使GRK2的丝氨酸685磷酸化。这种修饰增加了Gβγ亚基与GRK2的结合,从而增强了激酶转运到膜上并使受体磷酸化的能力。通过诱变(S685A)或表达显性负性AKAP79突变体消除GRK2上丝氨酸685的磷酸化,可减少GRK2介导的向β2AR的转运以及激动剂占据的β2AR的磷酸化,从而减少随后的受体内化。激动剂刺激的PKA介导的GRK2磷酸化可能代表一种增强受体磷酸化和脱敏的机制。